Interaction of clozapine with metformin in a schizophrenia rat model

Abstract The low efficacy of antipsychotic drugs (e.g., clozapine) for negative symptoms and cognitive impairment has led to the introduction of adjuvant therapies. Because previous data suggest the procognitive potential of the antidiabetic drug metformin, this study aimed to assess the effects of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: G. Horvath, G. Kis, G. Kekesi, A. Büki, L. G. Adlan, E. Szűcs, H. El Heni, S. Benyhe
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2d9dba62c9c244dd8d679eb05da2ea09
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2d9dba62c9c244dd8d679eb05da2ea09
record_format dspace
spelling oai:doaj.org-article:2d9dba62c9c244dd8d679eb05da2ea092021-12-02T16:45:41ZInteraction of clozapine with metformin in a schizophrenia rat model10.1038/s41598-021-96478-22045-2322https://doaj.org/article/2d9dba62c9c244dd8d679eb05da2ea092021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96478-2https://doaj.org/toc/2045-2322Abstract The low efficacy of antipsychotic drugs (e.g., clozapine) for negative symptoms and cognitive impairment has led to the introduction of adjuvant therapies. Because previous data suggest the procognitive potential of the antidiabetic drug metformin, this study aimed to assess the effects of chronic clozapine and metformin oral administration (alone and in combination) on locomotor and exploratory activities and cognitive function in a reward-based test in control and a schizophrenia-like animal model (Wisket rats). As impaired dopamine D1 receptor (D1R) function might play a role in the cognitive dysfunctions observed in patients with schizophrenia, the second goal of this study was to determine the brain-region-specific D1R-mediated signaling, ligand binding, and mRNA expression. None of the treatments affected the behavior of the control animals significantly; however, the combination treatment enhanced D1R binding and activation in the cerebral cortex. The Wisket rats exhibited impaired motivation, attention, and cognitive function, as well as a lower level of cortical D1R binding, signaling, and gene expression. Clozapine caused further deterioration of the behavioral parameters, without a significant effect on the D1R system. Metformin blunted the clozapine-induced impairments, and, similarly to that observed in the control animals, increased the functional activity of D1R. This study highlights the beneficial effects of metformin (at the behavioral and cellular levels) in blunting clozapine-induced adverse effects.G. HorvathG. KisG. KekesiA. BükiL. G. AdlanE. SzűcsH. El HeniS. BenyheNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
G. Horvath
G. Kis
G. Kekesi
A. Büki
L. G. Adlan
E. Szűcs
H. El Heni
S. Benyhe
Interaction of clozapine with metformin in a schizophrenia rat model
description Abstract The low efficacy of antipsychotic drugs (e.g., clozapine) for negative symptoms and cognitive impairment has led to the introduction of adjuvant therapies. Because previous data suggest the procognitive potential of the antidiabetic drug metformin, this study aimed to assess the effects of chronic clozapine and metformin oral administration (alone and in combination) on locomotor and exploratory activities and cognitive function in a reward-based test in control and a schizophrenia-like animal model (Wisket rats). As impaired dopamine D1 receptor (D1R) function might play a role in the cognitive dysfunctions observed in patients with schizophrenia, the second goal of this study was to determine the brain-region-specific D1R-mediated signaling, ligand binding, and mRNA expression. None of the treatments affected the behavior of the control animals significantly; however, the combination treatment enhanced D1R binding and activation in the cerebral cortex. The Wisket rats exhibited impaired motivation, attention, and cognitive function, as well as a lower level of cortical D1R binding, signaling, and gene expression. Clozapine caused further deterioration of the behavioral parameters, without a significant effect on the D1R system. Metformin blunted the clozapine-induced impairments, and, similarly to that observed in the control animals, increased the functional activity of D1R. This study highlights the beneficial effects of metformin (at the behavioral and cellular levels) in blunting clozapine-induced adverse effects.
format article
author G. Horvath
G. Kis
G. Kekesi
A. Büki
L. G. Adlan
E. Szűcs
H. El Heni
S. Benyhe
author_facet G. Horvath
G. Kis
G. Kekesi
A. Büki
L. G. Adlan
E. Szűcs
H. El Heni
S. Benyhe
author_sort G. Horvath
title Interaction of clozapine with metformin in a schizophrenia rat model
title_short Interaction of clozapine with metformin in a schizophrenia rat model
title_full Interaction of clozapine with metformin in a schizophrenia rat model
title_fullStr Interaction of clozapine with metformin in a schizophrenia rat model
title_full_unstemmed Interaction of clozapine with metformin in a schizophrenia rat model
title_sort interaction of clozapine with metformin in a schizophrenia rat model
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/2d9dba62c9c244dd8d679eb05da2ea09
work_keys_str_mv AT ghorvath interactionofclozapinewithmetformininaschizophreniaratmodel
AT gkis interactionofclozapinewithmetformininaschizophreniaratmodel
AT gkekesi interactionofclozapinewithmetformininaschizophreniaratmodel
AT abuki interactionofclozapinewithmetformininaschizophreniaratmodel
AT lgadlan interactionofclozapinewithmetformininaschizophreniaratmodel
AT eszucs interactionofclozapinewithmetformininaschizophreniaratmodel
AT helheni interactionofclozapinewithmetformininaschizophreniaratmodel
AT sbenyhe interactionofclozapinewithmetformininaschizophreniaratmodel
_version_ 1718383445433909248